印度制药公司正在整合AI, 以提高药品的发现和负担能力, 面对隐私和培训障碍。 Indian pharmaceuticals are integrating AI to boost drug discovery and affordability, facing privacy and training hurdles.

印度制药业以负担得起的药品闻名,正在采用AI和ML来改变药物发现、制造和个性化药品。 The Indian pharmaceutical industry, known for affordable medicines, is adopting AI and ML to transform drug discovery, manufacturing, and personalized medicine. 这一转变旨在提高效率和可负担性,但面临数据隐私和劳动力培训等挑战。 This shift aims to enhance efficiency and affordability but faces challenges like data privacy and workforce training. 技术公司、制药公司和政府之间的协作对于支持这种创新至关重要。 Collaboration among tech firms, pharmaceutical companies, and governments is essential to support this innovation.